The research & development by business enterprise, pharmaceutical industry in current ppp $ in Greece currently stands at 175.84 million, marking a decrease of 3.75 million (-2.1%) compared to 2020.
Research & development by business enterprise, pharmaceutical industry in current PPP $ in Greece
No matching regions
Similar regions to Greece
Business R&D pharmaceutical in current PPP $
More indicators for Greece
Government R&D in security as % of government support
1.41%
-0.09%
(2021)
Higher-education-finacing R&D financed by general university in local currency
3,734.72M
+65.42M
(2021)
R&D financed by rest of the world in local currency
3,806.09M
+208.69M
(2021)
Government R&D financed by rest of the world in local currency
920.23M
+200.43M
(2021)
Business R&D financed by rest of the world in local currency
1,625.81M
+254.61M
(2021)
Non-profit R&D growth rate
5.12%
+1.26%
(2022)
Greece Business R&D pharmaceutical in current PPP $ between 2011 and 2021
| Period | Business R&D pharmaceutical in current PPP $ | Change |
|---|---|---|
| 2021 | 175.84M | -3.75M |
| 2020 | 179.59M | +39.55M |
| 2019 | 140.04M | +35.32M |
| 2018 | 104.72M | +16.59M |
| 2017 | 88.13M | +17.96M |
| 2016 | 70.17M | +0.89M |
| 2015 | 69.29M | -14.92M |
| 2014 | 84.20M | -8.95M |
| 2013 | 93.16M | +9.27M |
| 2012 | 83.89M | -0.68M |
| 2011 | 84.57M |